USE OF BRADYCARDIAC SUBSTANCES FOR THE PREPARATION OF MEDICAMENTS FOR THE TREATMENT OF MYOCARDIAL DISEASES ASSOCIATED WITH HYPERTROPHY AND NOVEL MEDICAMENT COMBINATIONS

摘要

The invention relates to a novel use of bradycardiac substances such as a Ca++ channel blocker, beta-receptor blockers or i¿f? channel blockers, the if channel blockers being preferred. Said substances are optionally used in combination with a cardio-active substance for inducing the regression of myocardial diseases associated with hypertrophy, in particular for treating ideopathic hypertrophic cardiomyopathies (HCM) in humans and domestic animals.